Back to search
FDAFDA · Food and drugs·Recall number D-0504-2024

Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-653-01

Published May 29, 2024 · Recall initiated: May 1, 2024

Summary

FDA records drug Class III recall D-0504-2024, published May 29, 2024 and initiated May 1, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 1,176 bottles; Lot: Lot H2200493; Exp 6/30/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated

Get an email if SIROLIMUS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SIROLIMUS
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
US Nationwide.
UPC
0355111654018
Lot
Lot H2200493; Exp 6/30/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-653-01 recalled?

Yes. FDA published recall D-0504-2024 on May 29, 2024. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SIROLIMUS. UPC: 0355111654018.